The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy
- 1 November 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (5) , 1691-1699
- https://doi.org/10.1046/j.1523-1755.1999.00728.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrationsKidney International, 1998
- Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1Kidney International, 1996
- Diabetic nephropathy: molecular analysis of extracellular matrix and clinical studies updateNephrology Dialysis Transplantation, 1996
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.Journal of Clinical Investigation, 1994
- Structural-functional correlations of diabetic nephropathyKidney International, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Rat mesangial cell hypertrophy in response to transforming growth factor-β1Kidney International, 1993
- Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.Journal of Clinical Investigation, 1992
- Renal hypertrophy in experimental diabetes mellitusKidney International, 1983